PERSPECTIVE THERAPEUTICS, INC. Gain (Loss) on Disposition of Assets
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Gain (Loss) on Disposition of Assets of $1.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2020-05-13.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2020-05-13
- PERSPECTIVE THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2019-03-31 was $1.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 9 month |
|---|---|---|
| 2019-03-31 | $1.00K 10-Q · filed 2020-05-13 | $24.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |